ASX ANNOUNCEMENT 7 October 2026 1 Flavocide® contact efficacy and residual activity data against deer ticks published in peer-reviewed journal Ticks and Tick-borne Diseases Highlights • Results of a study conducted by researchers at Purdue University’s Department of Entomology have been...
Flavocide efficacy results against deer ticks published
Filed with ASX ·
6ix hasn’t read this filing yet.
Bio-Gene Technology Ltd. on 6ix
Earlier from Bio-Gene Technology
- Appendix 4E and 2026 Annual Report
- Corporate Governance Statement
- Appendix 4G
- Change in substantial holding
- Notification regarding unquoted securities - BGT
Later from Bio-Gene Technology
- Date of 2026 Annual General Meeting
- Bio-Gene Receives $343,000 R&D Tax Incentive
- Proposed issue of securities - BGT
- Quarterly Activities/Appendix 4C Cash Flow Report
- Notice of Annual General Meeting/Proxy Form
